ODV vs RNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ODV

52.0
AI Score
VS
RNA Wins

RNA

53.9
AI Score

Investment Advisor Scores

ODV

52score
Recommendation
HOLD

RNA

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ODV RNA Winner
Forward P/E 23.9808 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 2638.5% 1148.3% ODV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.0/100 53.9/100 RNA
Profit Margin -189.6% -160.0% RNA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ODV 1M: -18.3% · 3M: -32.6% RNA 1M: -14.7% · 3M: -11.1%

Current Technical Phase

ODV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.2%), weak momentum, RSI 37

RSI (14): 36.7 · Price: $2.27

RNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.1%), weak momentum, RSI 37

RSI (14): 37.0 · Price: $11.35

Fundamentals Snapshot

Metric ODV RNA
Market Cap
Forward P/E 24.0 -1.9
Trailing P/E
Revenue (TTM)
Revenue Growth 26.4% 11.5%
Gross Margin 0.6% -0.3%
Operating Margin -4.1% -0.9%
EPS -0.39 -5.02
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.